Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-08-16 , DOI: 10.1111/apt.16543
Thierry Poynard ₁ , Valérie Paradis ₁ , Jimmy Mullaert ₁ , Olivier Deckmyn ₁ , Nathalie Gault ₁ , Estelle Marcault ₁ , Pauline Manchon ₁ , Nassima Si Mohammed ₁ , Beatrice Parfait ₁ , Mark Ibberson ₂ , Jean-Francois Gautier ₁ , Christian Boitard ₁ , Sébastien Czernichow ₁ , Etienne Larger ₁ , Fabienne Drane ₁ , Jean Marie Castille ₁ , Valentina Peta ₁ , Angélique Brzustowski ₃ , Benoit Terris ₁ , Anais Vallet-Pichard ₁ , Dominique Roulot ₄ , Cédric Laouénan ₁ , Pierre Bedossa ₁ , Laurent Castera ₁ , Stanislas Pol ₁ , Dominique Valla _{1,

3} ,

Affiliation

One of the unmet needs in patients with type 2 diabetes mellitus (T2DM) is the prediction of non-alcoholic liver disease by non-invasive blood tests, for each of the three main histological features, fibrosis, non-alcoholic steatohepatitis (NASH) and steatosis.

中文翻译：